Visit the News Center Even short interventions are associated with changes in the risk of heart attack, stroke, and death Sarah Moser and Alaska Adams/Washio Medicine WashU drug researchers have found that stopping GLP-1 drugs like semaglutide and terzepatide — even temporarily — increases the risk of heart attack, stroke and death compared to staying … Read more
If there is a habit experts constantly recommend to support GLP-1, it gives priority to protein. Foods that include enough protein cause a strong release of the hormone, helping you feel fuller for longer. “Protein is one of the most powerful direct stimulators of GLP-1 release,” says Dr. Jean-Marc Sobchak, a doctor of naturopathy in … Read more
One study found that 55% of obese people regained the weight they lost after stopping GLP-1 medication, and so did 45% of diabetics. It also found that 45% of obese participants and 56% of diabetics lost weight or kept it off while off the medication. However, many of those who had successful outcomes still received … Read more
The city’s chief financial officer, Ashley Groffenberger, sent a letter to the City Council on Monday saying that health insurance rates for city employees are increasing nearly 23 percent in the fiscal year that begins in July — the highest year-over-year premium costs the city has seen “in recent history.” According to the city, Boston … Read more
Wu’s administration is considering cutting GLP-1 coverage for weight loss for Boston city workers because of “skyrocketing” health insurance costs that are straining city finances. Chief Finance Officer Ashley Groffenberger said in a letter to the Boston City Council on Monday that the city has confirmed that there will be a significant increase in employee … Read more
John “Gabby” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a distinct trend: Some patients taking GLP-1s would come away with significant respiratory injuries from a relatively minor physical excursion. For example, some suffer from rotator cuff tears in the shoulder area while Doing simple housework like vacuuming or raking leaves. “They didn’t necessarily … Read more
As the use of injectable GLP-1 drugs continues to increase, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that, on average, ceasing semaglutide and terzapatide does not lead to significant weight regain in clinical practice, as many patients later resume … Read more